{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:51:41Z","timestamp":1772578301281,"version":"3.50.1"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"7-8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Careful monitoring of the therapy is crucial for patients with congenital adrenal hyperplasia (CAH) in order to prevent the effects of increased androgen production as well as life-threatening salt-wasting crisis. The key metabolite, 17\u03b1-hydroxyprogesterone (17-OHP) can be detected in serum, saliva or dried blood. In clinical practice there are challenges due to discomfort of venous blood sampling and complicated retrieval of saliva during infancy. Furthermore, the immunoassay method is limited in its specificity due to cross-reactions. In this observational study we prospectively examined over a period of 5 years, 20 patients with CAH due to 21-hydroxylase deficiency using standard immunoassays for serum samples (radioimmunoassay and enzyme immunoassay) and liquid chromatography-tandem mass spectrometry (LC-MS\/MS) in dried blood spots. Bland-Altman plots show goodness of agreement between both the methods for the desirable therapeutic concentration range of 17-OHP. LC-MS\/MS is characterized by a high accuracy in the therapeutic concentration range of 17-OHP &lt;100 nmol\/L (<jats:italic>r<\/jats:italic>=0.91). Dried blood samples are convenient and reliable specimen for 17-OHP measured by LC-MS\/MS. This method could be used for home monitoring of hydrocortisone replacement therapy both in salt-waster and simple virilizer CAH.<\/jats:p>","DOI":"10.1515\/jpem-2014-0303","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T08:57:51Z","timestamp":1436777871000},"page":"867-871","source":"Crossref","is-referenced-by-count":13,"title":["Therapy monitoring in congenital adrenal hyperplasia by dried blood samples"],"prefix":"10.1515","volume":"28","author":[{"given":"Isabelle","family":"Wieacker","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Peter","sequence":"additional","affiliation":[{"name":"Screening Laboratory Hannover, Ronnenberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Borucki","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry; Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susann","family":"Empting","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich-Wilhelm","family":"Roehl","sequence":"additional","affiliation":[{"name":"Institute of Biometry and Medical Informatics; Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Mohnike","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2015,3,7]]},"reference":[{"key":"2022053105154302793_j_jpem-2014-0303_ref_001_w2aab2b8c37b1b7b1ab2ab1Aa","doi-asserted-by":"crossref","unstructured":"Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776\u201388.10.1056\/NEJMra021561","DOI":"10.1056\/NEJMra021561"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_002_w2aab2b8c37b1b7b1ab2ab2Aa","unstructured":"Orth DN, Kovacs WJ. Congenital adrenal hyperplasia. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, editors. Williams textbook of endocrinology, 9th ed. Philadelphia: W. B. Saunders Company, 1998:598\u2013605."},{"key":"2022053105154302793_j_jpem-2014-0303_ref_003_w2aab2b8c37b1b7b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"Merke DP. Approach to the adult with congenital adrenal hyperplasia due the 21-hydroxylase deficiency. J Clin Endocrinol Metab 2008;93:653\u201360.10.1210\/jc.2007-2417","DOI":"10.1210\/jc.2007-2417"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_004_w2aab2b8c37b1b7b1ab2ab4Aa","doi-asserted-by":"crossref","unstructured":"Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, et al. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation. J Clin Endocrinol Metab 2009;94:3882\u20138.10.1210\/jc.2009-0942","DOI":"10.1210\/jc.2009-0942"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_005_w2aab2b8c37b1b7b1ab2ab5Aa","doi-asserted-by":"crossref","unstructured":"Trakakis E, Basios G, Trompoukis P, Labos G, Grammatikakis I, et al. An update to 21-hydroxylase deficient congenital adrenal hyperplasia. Gynecol Endocrinol 2010;26:63\u201371.10.3109\/09513590903015494","DOI":"10.3109\/09513590903015494"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_006_w2aab2b8c37b1b7b1ab2ab6Aa","doi-asserted-by":"crossref","unstructured":"Antal Z, Zhou P. Congenital adrenal hyperplasia: diagnosis, evaluation, and management. Pediatr Rev 2009;30:49\u201357.10.1542\/pir.30.7.e49","DOI":"10.1542\/pir.30-7-e49"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_007_w2aab2b8c37b1b7b1ab2ab7Aa","doi-asserted-by":"crossref","unstructured":"Hindmarsh PC. Management of the child with congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 2009;23:193\u2013208.10.1016\/j.beem.2008.10.010","DOI":"10.1016\/j.beem.2008.10.010"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_008_w2aab2b8c37b1b7b1ab2ab8Aa","doi-asserted-by":"crossref","unstructured":"New MI, Levine LS. Recent advances in 21-hydroxylase deficiency. Annu Rev Med 1984;35:649\u201363.10.1146\/annurev.me.35.020184.003245","DOI":"10.1146\/annurev.me.35.020184.003245"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_009_w2aab2b8c37b1b7b1ab2ab9Aa","doi-asserted-by":"crossref","unstructured":"Young MC, Robinson JA, Read GF, Riad-Fahmy D, Hughes IA. 170H-progesterone rhythms in congenital adrenal hyperplasia. Arch Dis Child 1988;63:617\u201323.10.1136\/adc.63.6.617","DOI":"10.1136\/adc.63.6.617"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_010_w2aab2b8c37b1b7b1ab2ac10Aa","doi-asserted-by":"crossref","unstructured":"S\u00f3lyom J. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 1981;14:547\u201353.10.1111\/j.1365-2265.1981.tb02964.x","DOI":"10.1111\/j.1365-2265.1981.tb02964.x"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_011_w2aab2b8c37b1b7b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"Riordan FA, Wood PJ, Wakelin K, Betts P, Clayton BE. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy. Lancet 1984;323:708\u201311.10.1016\/S0140-6736(84)92223-2","DOI":"10.1016\/S0140-6736(84)92223-2"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_012_w2aab2b8c37b1b7b1ab2ac12Aa","doi-asserted-by":"crossref","unstructured":"Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, et al. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004;89:3687\u201393.10.1210\/jc.2003-032235","DOI":"10.1210\/jc.2003-032235"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_013_w2aab2b8c37b1b7b1ab2ac13Aa","doi-asserted-by":"crossref","unstructured":"Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, et al. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2007;92:2581\u20139.10.1210\/jc.2006-2890","DOI":"10.1210\/jc.2006-2890"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_014_w2aab2b8c37b1b7b1ab2ac14Aa","doi-asserted-by":"crossref","unstructured":"Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Med Res 1999;8:135\u201360.10.1177\/096228029900800204","DOI":"10.1191\/096228099673819272"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_015_w2aab2b8c37b1b7b1ab2ac15Aa","doi-asserted-by":"crossref","unstructured":"Robinson JA, Dyas J, Hughes IA, Riad-Fahmy D. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia. Ann Clin Biochem 1987;24:58\u201365.10.1177\/000456328702400109","DOI":"10.1177\/000456328702400109"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_016_w2aab2b8c37b1b7b1ab2ac16Aa","doi-asserted-by":"crossref","unstructured":"Shimon I, Kaiserman I, Sack J. Home monitoring of 17 alpha-hydroxyprogesterone levels by filter paper blood spots in patients with 21-hydroxylase deficiency. Horm Res 1995;44:247\u201352.10.1159\/000184636","DOI":"10.1159\/000184636"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_017_w2aab2b8c37b1b7b1ab2ac17Aa","doi-asserted-by":"crossref","unstructured":"Bode HH, Rivkees SA, Cowley DM, Pardy K, Johnson S. Home monitoring of 17 hydroxyprogesterone levels in congenital adrenal hyperplasia with filter paper blood samples. J Pediatr 1999;134:185\u20139.10.1016\/S0022-3476(99)70413-0","DOI":"10.1016\/S0022-3476(99)70413-0"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_018_w2aab2b8c37b1b7b1ab2ac18Aa","doi-asserted-by":"crossref","unstructured":"Sarafoglou K, Himes JH, Lacey JM, Netzel BC, Singh RJ, et al. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia. Horm Res Paediatr 2011;75:19\u201325.10.1159\/000315910320293020798478","DOI":"10.1159\/000315910"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_019_w2aab2b8c37b1b7b1ab2ac19Aa","doi-asserted-by":"crossref","unstructured":"Shibayama Y, Higashi T, Shimada K, Kashimada K, Onishi T, et al. Liquid chromatography-tandem mass spectrometric method for determination of salivary 17alpha-hydroxyprogesterone: a noninvasive tool for evaluating efficacy of hormone replacement therapy in congenital adrenal hyperplasia. J Chromatogr B Analyt Technol Biomed Life Sci 2008;867:49\u201356.10.1016\/j.jchromb.2008.03.00918378505","DOI":"10.1016\/j.jchromb.2008.03.009"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_020_w2aab2b8c37b1b7b1ab2ac20Aa","doi-asserted-by":"crossref","unstructured":"Hughes IA, Dyas J, Robinson J, Walker RF, Fahmy DR. Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva. Ann NY Acad Sci 1985;458:193\u2013202.10.1111\/j.1749-6632.1985.tb14604.x3879122","DOI":"10.1111\/j.1749-6632.1985.tb14604.x"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_021_w2aab2b8c37b1b7b1ab2ac21Aa","doi-asserted-by":"crossref","unstructured":"Dauber A, Kellogg M, Majzoub JA. Monitoring of therapy in congenital adrenal hyperplasia. Clin Chem 2010;56:1245\u201351.10.1373\/clinchem.2010.14603520558634","DOI":"10.1373\/clinchem.2010.146035"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_022_w2aab2b8c37b1b7b1ab2ac22Aa","doi-asserted-by":"crossref","unstructured":"Rauh M. Steroid measurement with LC-MS\/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol 2010;121:520\u20137.10.1016\/j.jsbmb.2009.12.00720036331","DOI":"10.1016\/j.jsbmb.2009.12.007"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_023_w2aab2b8c37b1b7b1ab2ac23Aa","unstructured":"Hubl W, Feh\u00e9r T, Rohde W, D\u00f6rner G, Taubert H, et al. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia. Endokrinologie 1982;79: 165\u201372."},{"key":"2022053105154302793_j_jpem-2014-0303_ref_024_w2aab2b8c37b1b7b1ab2ac24Aa","doi-asserted-by":"crossref","unstructured":"Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977;45:1003\u20138.10.1210\/jcem-45-5-1003925125","DOI":"10.1210\/jcem-45-5-1003"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_025_w2aab2b8c37b1b7b1ab2ac25Aa","doi-asserted-by":"crossref","unstructured":"Schwarz E, Liu A, Randall H, Haslip C, Keune F, et al. Use of steroid profiling by UPLC-MS\/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience. Pediatr Res 2009;66:230\u20135.10.1203\/PDR.0b013e3181aa377719390483","DOI":"10.1203\/PDR.0b013e3181aa3777"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_026_w2aab2b8c37b1b7b1ab2ac26Aa","doi-asserted-by":"crossref","unstructured":"Rossi C, Calton L, Hammond G, Brown HA, Wallace AM, et al. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography\u2013tandem mass spectrometry. Clin Chim Acta 2010;411:222\u20138.10.1016\/j.cca.2009.11.00719931522","DOI":"10.1016\/j.cca.2009.11.007"},{"key":"2022053105154302793_j_jpem-2014-0303_ref_027_w2aab2b8c37b1b7b1ab2ac27Aa","doi-asserted-by":"crossref","unstructured":"Janzen N, Sander S, Terhardt M, Steuerwald U, Peter M, et al. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry. Steroids 2011;76:1437\u201342.10.1016\/j.steroids.2011.07.01321839763","DOI":"10.1016\/j.steroids.2011.07.013"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2014-0303\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2014-0303\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T05:16:45Z","timestamp":1653974205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2014-0303\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,7]]},"references-count":27,"journal-issue":{"issue":"7-8","published-online":{"date-parts":[[2015,3,7]]},"published-print":{"date-parts":[[2015,7,1]]}},"alternative-id":["10.1515\/jpem-2014-0303"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2014-0303","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3,7]]}}}